Insight Molecular Diagnostics Inc. IMDX
Rating
Rating Factors
Company Overview
Insight Molecular Diagnostics Inc. (ticker: IMDX) appears to be a molecular diagnostics and life sciences company focused on diagnostic testing technologies and related healthcare applications. Publicly available information indicates the company has been associated with molecular testing, laboratory diagnostics, and healthcare technology activities; however, detailed and consistently verified disclosures regarding its current commercial operations, product portfolio, and financial performance are limited across major public databases and regulatory filings.
Available public records do not provide sufficient independently verified detail to fully confirm the company’s current revenue drivers, market positioning, customer base, or competitive advantages. Data inconclusive based on available public sources regarding the company’s operational scale, historical development milestones, and current strategic positioning.
Income Statement
Balance Sheet
Cash Flow
Filings
Price History
- Low
- $2.42
- Current
- $3.92
- High
- $8.51
Valuation
Dividends and Shares
Corporate Info
Suite 510
Nashville, TN 37217